Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Imiquimod and Abraxane for Breast Cancer Cutaneous Metastases
NCT00821964Phase 2Completed
- Sponsor
- University of Washington
- Start
- Dec 2008
- Primary completion
- Nov 2012
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of imiquimod in breast cancer, sponsored by University of Washington. Started Dec 2008; status: completed.
02
Drugs
imiquimod
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00821964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00821964.